BaseClear has years of experience in microbiome analysis, including the analysis of interactions between drugs and the microbiota in clinical trials. The microbiota plays an important role in the efficacy, effectiveness and safety of many drugs, probiotics, cosmetics and other biological compounds. The microbiota influences the bioavailability, toxicity and responsiveness of a patient to a given drug. In opposite, the profile of a patient’s microbiome can predict how the patient responds to a drug.
We routinely organise expert meetings wherein scientists and researchers meet, share and discuss microbiome projects, challenges and opportunities. On Thursday September 5th, we are once again organising an 1-day expert-meeting titled:
Microbiome analysis for clinical trials
An experts meeting to discuss microbiome-based clinical research